All Episodes

July 15, 2025 58 mins

Send us a text

In this episode of Causes or Cures, Dr. Eeks chats with immunology expert Dr. Maziar “Maz” Divangahi about how a fiber found in mushrooms may help us beat the flu, and he introduces us to the concept of disease tolerance. 

What We’ll Cover

  1. Beta-Glucan 101
    • What it is: a natural fiber in the outer wall of fungi (think mushrooms).
    • Why it matters: mounting evidence says it can help you fight off the flu by improving something called disease tolerance. 
  2. Two Immune Playbooks
    • Host Resistance: the classic “seek and destroy” tactic.
    • Disease Tolerance: a quieter, damage-control strategy our bodies use to stay functional even when a pathogen sticks around.
    • Dr. Maz will unpack how beta-glucan may tilt the balance toward disease tolerance.
  3. From TB Labs to Flu Research
    • Insights from Dr. Maz’s tuberculosis studies that set the stage for his beta-glucan–flu work.
    • Early data on how this fungal fiber might boost flu-specific disease tolerance.
  4. Should We Eat More Mushrooms or Supplement?
    • Practical tips and caveats on dietary vs. supplemental beta-glucan.
    • What the current evidence actually supports.
  5. Beyond Infections: Beta-Glucan in Cancer Trials
    • Snapshot of ongoing studies in breast and bladder cancer.
    • Why disease tolerance is a hot oncology frontier.
  6. Future Directions & Take-Home Points
    • Where Dr. Maz’s research is headed next.
    • Simple, science-backed actions listeners can try today.

Listen If You’ve Ever Wondered…

  • Why some people sail through the flu while others end up in the ER.
  • Whether “disease tolerance” might rewrite how we tackle pandemics.
  • If tossing extra shiitakes into your stir-fry can really make a difference.

Dr. Maziar (Maz) Divangahi is a Professor of Medicine at McGill University. He is the Associate Director of the Meakins-Christie Laboratories and the Associate Director of the McGill Interna onal TB Centre. He is an internationally recognized pulmonary immunologist and the overarching focus of his research program is to inves gate the regulatory mechanisms involved in host resistance and disease tolerance against major pulmonary bacterial (Mycobacterium tuberculosis) and viral (influenza virus and SARS-CoV2) pathogens. He is currently inves ga ng how to harness the power of innate memory response (Trained Immunity) in vaccine development. Throughout his career, he has been a prolifera ve inves gator publishing in outstanding journals and received numerous awards, including a CIHR New Inves gator Award, FRQS Award, and the CIHR Founda on grant. His scholarly work has been recognized by elec on to the Royal Society of Canada. He is currently holding the Strauss Chair in Respiratory Diseases. 

You can contact Dr. Eeks at bloomingwellness.com.
Follow Eeks on Instagram here.
Or Facebook here.
Or X.
On Youtube.
Or TikTok.
SUBSCRIBE to her monthly newsletter here! (Now featuring interviews with top experts on health you care about!)

Support the show


Advertise With Us

Popular Podcasts

Las Culturistas with Matt Rogers and Bowen Yang

Las Culturistas with Matt Rogers and Bowen Yang

Ding dong! Join your culture consultants, Matt Rogers and Bowen Yang, on an unforgettable journey into the beating heart of CULTURE. Alongside sizzling special guests, they GET INTO the hottest pop-culture moments of the day and the formative cultural experiences that turned them into Culturistas. Produced by the Big Money Players Network and iHeartRadio.

Dateline NBC

Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com

24/7 News: The Latest

24/7 News: The Latest

The latest news in 4 minutes updated every hour, every day.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.